Compugen (CGEN) Accounts Payables (2009 - 2026)
Compugen (CGEN) posted quarterly Accounts Payables of $2.5 million for Q1 2026, down 76.92% year-over-year from $10.9 million in Q1 2025, and up 7.35% on a QoQ basis from $2.4 million in Q4 2025.
Analysis
Compugen (CGEN) Accounts Payables (2009 - 2026) Analysis & Trends
Compugen has reported Accounts Payables for 18 years, with the latest figure at $2.5 million in Q1 2026.
- Accounts Payables for Q1 2026 came in at $2.5 million, down 76.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.5 million (down 76.92% YoY), and the FY2025 annual result was $2.4 million, up 28.02% from the prior year.
- Accounts Payables rose to $2.5 million in Q1 2026, from $2.4 million in the prior quarter.
- Over five years, Accounts Payables peaked at $14.5 million in Q4 2023 and troughed at $1.7 million in Q2 2023.
- A 5-year average of $7.6 million and a median of $9.8 million in 2023 frame the typical range for Accounts Payables.
- The widest annual swing landed in 2022, when Accounts Payables surged 137.63%; it then tumbled 87.31% in 2024.
- A 5-year view of Accounts Payables shows it stood at $11.0 million in 2022, then jumped by 31.91% to $14.5 million in 2023, then slumped by 87.31% to $1.8 million in 2024, then climbed by 28.02% to $2.4 million in 2025, then grew by 7.35% to $2.5 million in 2026.
- Per Business Quant data, the three most recent Accounts Payables figures were $2.5 million in Q1 2026, $2.4 million in Q4 2025, and $9.1 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 167.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 88.42 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 470.30 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 108.02 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 35.57 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Compugen | 242.44 Mn | 156.82 Mn | -92,000.00 | 2.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.16 Mn |
| Mar 31, 2026 | 2.53 Mn |
| Dec 31, 2025 | 2.35 Mn |
| Sep 30, 2025 | 9.12 Mn |
| Jun 30, 2025 | 1.79 Mn |
| Mar 31, 2025 | 10.94 Mn |
| Dec 31, 2024 | 1.84 Mn |
| Sep 30, 2024 | 11.40 Mn |
| Jun 30, 2024 | 2.38 Mn |
| Mar 31, 2024 | 13.43 Mn |
| Dec 31, 2023 | 3.50 Mn |
| Sep 30, 2023 | 9.78 Mn |
| Jun 30, 2023 | 1.68 Mn |
| Mar 31, 2023 | 10.10 Mn |
| Dec 31, 2022 | 1.77 Mn |
| Sep 30, 2022 | 12.52 Mn |
| Jun 30, 2022 | 2.15 Mn |
| Mar 31, 2022 | 11.45 Mn |
| Dec 31, 2021 | 4.62 Mn |
| Sep 30, 2021 | 13.66 Mn |